Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02351648
Other study ID # 2012/848/E
Secondary ID
Status Completed
Phase N/A
First received January 21, 2015
Last updated January 29, 2015
Start date October 2012
Est. completion date December 2014

Study information

Verified date January 2015
Source Singapore General Hospital
Contact n/a
Is FDA regulated No
Health authority Singapore: Institutional Review Board
Study type Interventional

Clinical Trial Summary

To find out if a transitional care model can reduce the rate of unscheduled readmission to the Department of Internal Medicine (DIM) in SGH


Description:

Hospital with high readmission rate is view as having lower quality of care High readmission rate is view as wasteful healthcare spending

Primary Aim:

To find out if a transitional care model can reduce the rate of unscheduled readmission to the Department of Internal Medicine (DIM) in SGH A readmission episode is defined as an episode of readmission to any tertiary hospital within 30 days after index discharge from SGH

Secondary Aim:

To find out if a transitional care model can reduce the number of visits to the emergency department in SGH To find out the quality of our transitional care model by using a care transition measure (CTM-15)


Recruitment information / eligibility

Status Completed
Enrollment 840
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 21 Years and older
Eligibility Inclusion criteria

-More than 1 admission in the last 90 days

Exclusion Criteria

- Subject is a non-resident

- Subject has no local home address

- Subject is from a long-term care facility during index admission

- Subject is unable to participate in telephone surveillance

- Subject is discharged before takeover

- Subject has impaired decision making capacity without surrogate decision maker

- Subject is pending or currently in critical care unit

- Subject or caregiver is mentally unstable

- Subject is haemodynamically unstable

- Subject requires acute inpatient respiratory support

- Subject requires acute inpatient dialysis support

- Subject pending surgical intervention

- Subject pending transfer to other specialist discipline

- Primary team consultant declined to participate in this research

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Other:
a transitional care model
Intervention extend from transfer of care to the study team from the initial admission medical team through 90 days after discharge Intervention in hospital includes the following. Comprehensive discharge planning based on the 6 principles. Discharge planning initially within 24 hours of recruitment Daily ward review of patients Weekly multi-disciplinary meeting Consolidation of medication and follow-up appointment before discharge Assessment of needs before discharge Comprehensive discharge summary and medication record at discharge Intervention after discharge: Work done mainly by integrated care nurse Review of patients within 48 hours after discharge via home visit or phone call Subsequent home visit as needed based on patient's needs At least weekly contact with pt or caregiver via telephone Telephone availability working weekday 8 AM to 5 PM Multi-disciplinary meeting for problematic cases Use chronic disease pathway for suitable patients
Control
Patients receive usual standard of care from the internal medicine team

Locations

Country Name City State
Singapore Singapore General Hospital Singapore

Sponsors (3)

Lead Sponsor Collaborator
Singapore General Hospital Agency for Integrated Care, Singapore, Duke-NUS Graduate Medical School

Country where clinical trial is conducted

Singapore, 

References & Publications (3)

Coleman EA, Smith JD, Frank JC, Eilertsen TB, Thiare JN, Kramer AM. Development and testing of a measure designed to assess the quality of care transitions. Int J Integr Care. 2002;2:e02. Epub 2002 Jun 1. — View Citation

Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003 Feb 4;138(3):161-7. — View Citation

Mistiaen P, Poot E. Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004510. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Readmission rate A readmission episode is defined as an episode of readmission to any tertiary hospital within 30 days after index discharge from SGH Readmission rate is calculated by dividing the total number of admission by the total number of patients 30 days after index discharge No
Secondary Readmission rate Readmission rate is calculated by dividing the total number of admission by the total number of patients. This will measured at 7 days, 90 days and 180 days of discharge up to 180 days after index discharge No
Secondary Quality of transitional care using a validated care transition measure (CTM-15) tool Care transition measure survey of subjects 90 days after index discharge No
Secondary Emergency department attendance rate Emergency department attendance rate is calculated by dividing the total number of emergency department visits by the total number of patients. This will measured at 7 days, 30 days, 90 days and 180 days of discharge Up to 180 days after index discharge No
Secondary Time to first readmission Censored time to readmission for both intervention and control group Up to 90 days after index discharge No
Secondary Specialist Outpatient Clinic visits Outpatient clinic visit rate is calculated by dividing the total number of outpatient clinic visits by the total number of patients. This will measured at 90 days and 180 days of discharge Up to 180 days after index discharge No
See also
  Status Clinical Trial Phase
Completed NCT02694796 - Impact of Web and Smartphone-based Physical Activity Program on Physical Activity Level 12 Months After a Balneotherapy N/A
Completed NCT00772733 - A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment N/A
Completed NCT00126737 - Home-Based Exercise and Weight Control Program for Pain Control in Overweight Elderly With Osteoarthritis of the Knee N/A
Completed NCT01719991 - Vulnerable Patients in Primary Care: Nurse Case Management and Self-management Support N/A
Completed NCT00569595 - Improving Health Habits in Impoverished Populations Phase 3
Completed NCT00309296 - Longitudinal Care: Smoking Reduction to Aid Cessation N/A
Completed NCT02487589 - Falls in Elderly and Telehealth: a Randomized Controlled Study N/A
Recruiting NCT00172926 - Study on the Relationship Between Physical Constitution and Diseases N/A
Completed NCT00222703 - Enhancing Tobacco Abstinence Following Hospitalization N/A
Recruiting NCT05233917 - Dietary Metabolic Signatures in Health Study
Active, not recruiting NCT05247632 - Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study
Completed NCT02885129 - Development of the General Scale Observance for Chronic Diseases N/A
Completed NCT01832064 - Active Living Tool Kit for Chronic Conditions N/A
Completed NCT01625468 - Brief Interventions to Create Smoke-Free Home Policies in Low-Income Households N/A
Completed NCT00341536 - Feasibility Study for Prospective Diet and Lifestyle Cohorts in Delhi, Kerala, and Kolkota, India
Not yet recruiting NCT06046326 - Evaluate the Effectiveness of a Virtual Community of Practice N/A
Completed NCT06179238 - Urinary Catheter Self-care Management N/A
Active, not recruiting NCT02637869 - Evaluating Community Health Centers' Adoption of a New Global Capitation Payment
Completed NCT02191111 - A Cluster-randomized Controlled Knowledge Translation Feasibility Study in Alberta Community Pharmacies N/A
Completed NCT01372137 - First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94 Phase 1